Abstract
Background: A joint committee of the European Society of Cardiology and the American College of Cardiology (ESC/ACC) recently redefined myocardial infarction.
Hypothesis: The objective of this study was to examine the outcome of diagnoses from more than 500 patients admitted to a university hospital coronary care unit (CCU), when the ESC/ACC committee cut‐off levels were compared with the Swedish diagnostic criteria for acute myocardial infarction (MI), comparable with everyday practice in most countries.
Methods: Creatine kinase‐MB, troponin I, and troponin T were measured in 525 patients admitted consecutively to the CCU, Huddinge University Hospital, with possible myocardial ischemia lasting < 12 h before arrival.
Results: The ESC/ACC definition of MI increased the number of MIs by 3‐32% compared with the number achieved when Swedish diagnostic criteria for acute MI were used. A significant number of patients with elevated cardiac enzymes presented with acute heartfailure, tachycardia, pulmonary embolism, and sepsis as initial symptom.
Conclusions: In this study of more than 500 patients with possible myocardial ischemia admitted consecutively to the CCU at a university hospital, the ESC/ACC definition of MI increased the number of MIs by 3‐32% compared with the number achieved when Swedish diagnostic criteria for acute MI were used. A majority of the patients identified with ESC/ACC cut‐off levels presented with myocardial ischemia as the primary symptom, whereas many of the other patients had acute heart failure and tachycardia as initial symptom. It is unclear whether patients in this latter group should be labelled as having MI; there are no clinical studies providing guidance in this situation.
Keywords: myocardial infarction, troponin, definition, creatine kinase‐MB
Full Text
The Full Text of this article is available as a PDF (35.5 KB).
References
- 1. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined: A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000; 36: 959–969 [DOI] [PubMed] [Google Scholar]
- 2. Morrow DA, Rifai N, Tanasijevic MJ, Wybenga DR, De Lemos JA, Antman EM: Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: A Thrombolysis in Myocardial Infarction (TIMI) IIB substudy. Clin Chem 2000; 46: 453–460 [PubMed] [Google Scholar]
- 3. Ohman EM, Armstrong PW, Christenson RH: Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med 1996; 335: 1333–1341 [DOI] [PubMed] [Google Scholar]
- 4. Lindahl B, Diderholm E, Lagerqvist B, Venge P, Wallentin L: Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: A FRISCII substudy. J Am Coll Cardiol 2001; 38: 979–986 [DOI] [PubMed] [Google Scholar]
- 5. Venge P, Lagerqvist B, Diderholm E, Lindahl B, Wallentin L: Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease. Am J Cardiol 2002; 89: 1035–1041 [DOI] [PubMed] [Google Scholar]
- 6. Morrow DA, Cannon CP, Rifai N, Frey MJ, Vicari R, Lakkis N, Robertsson DH: Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non‐ST elevation myocardial infarction: Results from a randomized trial. J Am Med Assoc 2001; 286: 2405–2412 [DOI] [PubMed] [Google Scholar]
- 7. Apple FS, Quist HE, Doyle PJ, Otto AP, Murakami MM: Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations. Clin Chem 2003; 49: 1331–1336 [DOI] [PubMed] [Google Scholar]
- 8. Wallentin L, Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E: Outcome at 1 year after an invasive compared with a non‐invasive strategy in unstable coronary‐artery disease: The FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during In Stability in Coronary artery disease. Lancet 2000; 356: 9–16 [DOI] [PubMed] [Google Scholar]
- 9. Altinier S, Mion M, Cappelletti A, Zaninotto M, Plebani M: Rapid measurement of cardiac markers on Stratus CS. Clin Chem 2000; 46: 991–993 [PubMed] [Google Scholar]
- 10. Chapelle JP, Aldenhoff MC, Pierard L, Gielen J: Comparison of cardiac troponin I measurements on whole blood and plasma on the Stratus CS analyzer and comparison with AxSYM. Clin Chem 2000; 46: 1864–1866 [PubMed] [Google Scholar]
- 11. Stenestrand U, Wallentin L: Swedish Register of Cardiac Intensive Care (RIKS‐HIA). Early statin treatment following acute myocardial infarction and 1‐year survival. J Am Med Assoc 2001; 31: 430–436 [DOI] [PubMed] [Google Scholar]
- 12. Higgins JP, Higgins JA: Elevation of cardiac troponin I indicates more than myocardial ischemia. Clin Invest Med 2003; 26: 133–147 [PubMed] [Google Scholar]
- 13. Panteghini M, Pagani F, Yeo KT, Apple FS, Christenson RH, Dati F, Mair J: Evaluation of imprecision for cardiac troponin assays at low‐range concentrations. Clin Chem 2004; 50: 327–332 [DOI] [PubMed] [Google Scholar]
- 14. Kontos MC, Fritz LM, Anderson FP, Tatum JL, Ornato JP, Jesse RL: Impact of the troponin standard on the prevalence of acute myocardial infarction. Am Heart J 2003; 146: 446–452 [DOI] [PubMed] [Google Scholar]
- 15. Meier MA, Al‐Badr WH, Cooper JV, Kline‐Rogers EM, Smith DE, Eagle KA, Metha RH: The new definition of myocardial infarction: Diagnostic and prognostic implications in patients with acute coronary syndromes. Arch Intern Med 2002; 162: 1585–1589 [DOI] [PubMed] [Google Scholar]
- 16. Spies C, Haude V, Fitzner R, Schroder K, Overbeck M, Runkel N, Schaffartzik W: Serum cardiac troponin T as a prognostic marker in early sepsis. Chest 1998; 113: 1055–1063 [DOI] [PubMed] [Google Scholar]
- 17. Baillard C, Boussarsar M, Fosse JP, Girou E, Le Toumelin P, Cracco C, Jaber S: Cardiac troponin I in patients with severe exacerbation of chronic obstructive pulmonary disease. Intens Care Med 2003; 29: 584–589 [DOI] [PubMed] [Google Scholar]
- 18. Zellweger MJ, Schaer BA, Cron TA, Pfisterer ME, Osswald S: Elevated troponin levels in absence of coronary artery disease after supraventricular tachycardia. Swiss Med Wkly 2003; 133: 439–441 [DOI] [PubMed] [Google Scholar]
- 19. Horwich TB, Patel J, MacLellan WR, Fonarow GC: Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 2003; 108: 833–838 [DOI] [PubMed] [Google Scholar]